ODOlga Anatolievna Dontsova

Olga Anatolievna Dontsova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Olga Anatolievna Dontsova has a total of 55 co-authors. Here are the top co-authors by number of shared publications:

  • Petr V. Sergiev

    Department of Chemistry and Belozersky Institute of Physico-Chemical Biology; Moscow State University; Moscow 119899 Russia

    4 shared publications
  • Alexey A. Bogdanov

    Department of Chemistry and A.N. Belozersky Institute of Physico-Chemical Biology, Moscow State University, Moscow, 119992, Russia

    3 shared publications
  • Alexey A. Bogdanov

    Department of Chemistry and A.N. Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow 119992, Russia

    2 shared publications
  • Cheng-Hang Sun

    Department of Microbial Chemistry, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China

    2 shared publications
  • Dmitry V. Lesnyak

    Department of Bioinformatics and Bioengineering, Moscow State University, Moscow 119992, Russia

    2 shared publications
  • Ilya Andreevich Osterman

    Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel

    2 shared publications

Latest Publications

  • Open Access

    Hetiamacin E and F, New Amicoumacin Antibiotics from Bacillus subtilis PJS Using MS/MS-Based Molecular Networking

    by Ting Wang, Qinpei Lu, Chenghang Sun, Dmitrii Lukianov, Ilya Andreevich Osterman, Petr Vladimirovich Sergiev, Olga Anatolievna Dontsova, Xinxin Hu, Xuefu You, Shaowei Liu, et al.

    To combat escalating levels of antibiotic resistance, novel strategies are developed to address the everlasting demand for new antibiotics. This study aimed at investigating amicoumacin antibiotics from the desert-derived Bacillus subtilis PJS by using the modern MS/MS-based molecular networking approach. Two new amicoumacins, namely hetiamacin E (1) and hetiamacin F (2), were finally isolated. The planar structures were determined by analysis of extensive NMR spectroscopic and HR–ESI–MS data, and the absolute configurations were concluded by analysis of the CD spectrum. Hetiamacin E (1) showed strong antibacterial activities against methicillin-sensitive and resistant Staphylococcus epidermidis at 2–4 µg/mL, and methicillin-sensitive and resistant Staphylococcus aureus at 8–16 µg/mL. Hetiamacin F (2) exhibited moderate antibacterial activities against Staphylococcus sp. at 32 µg/mL. Both compounds were inhibitors of protein biosynthesis demonstrated by a double fluorescent protein reporter system.


  • Open Access

    Exploitation of Potentially New Antibiotics from Mangrove Actinobacteria in Maowei Sea by Combination of Multiple Discovery Strategies

    by Qin-Pei Lu, Jing-Jing Ye, Yong-Mei Huang, Di Liu, Li-Fang Liu, Kun Dong, Elizaveta A. Razumova, Ilya A. Osterman, Petr V. Sergiev, Olga A. Dontsova, et al.

    Rediscovery of known antibiotics from actinobacteria, especially Streptomyces, has become a bottleneck issue. Nowadays, more specific identification and dereplication could be acquired by a combination of modern analytic techniques with various databases. In this study, 261 actinobacterial strains were isolated from 8 mangrove soil samples by culture-dependent method. A total of 83 strains were selected to evaluate antibacterial activities and mechanisms by disc diffusion method and a unique double fluorescent protein reporter system (pDualrep2), respectively. Thirty-two strains exhibited antagonistic activity against at least one of the “ESKAPE” pathogens. Four Streptomyces strains (B475, B486, B353, and B98) showed strong inhibitory activity against Gram-positive bacteria and induced DNA damage SOS response. One Micromonospora strain (B704) exhibited inhibitory activity against several pathogens and induced attenuation-based translational inhibitors reporter. Seven members of quinoxaline-type antibiotics including quinomycin A, quinomycin monosulfoxide, and other five putative new analogues were found from the culture broth of strain B475 by a combination of anti-MRSA guide, HPTLC, HPLC-UV, and UPLC-UV-HRESIMS/MS analysis, Chemspider searching, and MS/MS-based molecular networking analysis. In conclusion, this study not only demonstrated that mangrove is a rich source of actinobacteria with the potentially new antibiotics but showed rapid dereplication of known antibiotics in the early stage can improve efficiency for the discovery of new antibiotics.


  • Modern Site-Directed Cross-Linking Approaches: Implication for Ribosome Structure and Functions

    by Alexey A. Bogdanov, Petr V. Sergiev, Inna N. Lavrik, Olga V. Spanchenko, Andrey A. Leonov, Olga A. Dontsova

  • Telomerase from yeast Saccharomyces cerevisiae is active in vitro as a monomer

    by D. M. Shcherbakova, K. A. Sokolov, M. I. Zvereva, O. A. Dontsova

    A system for isolation of yeast telomerase viaRNA affinity tag in TLC1 RNA was developed. Streptavidin aptamer was inserted at two different positions in TLC1 RNA. Telomerase with TLC1 RNA with one...


  • Open Access

    The Regulation of Telomerase in Oncogenesis

    by D A Skvortzov, M P Rubzova, M E Zvereva, F L Kiselev, O A Donzova

    Telomerase is a complex ribonucleoprotein that completes the telomeres' ends in eukaryotic cells which shorten due to DnA underreplication. the core enzyme consists of a protein catalytic subunit—telomerase reverse transcriptase (tert)—and telomeric rnA (telomerase rnA (tr)); a small region of this rnA serves as a template for the telomeric repeats synthesis. Apart from rare exceptions, telomerase is not active in the somatic cells and tissues of the human body. However, the activation of telomerase activity in cancer cells was shown for certain in 80–90 % of cases. understanding the mechanism of telomerase functioning and the mechanisms of its regulation could be used in oncodiagnostics. telomerase itself and its regulators could be important targets for anticancer therapy. the activity of telomerase in a cell is affected by proteins with multiple functions, and this influence is not necessarily specific. there are also cases when telomerase regulators act together or when several regulators are organised in the cascade. the aim of this review is to generalize and systemize data about the regulation of telomerase in ontogenesis. Key words: telomerase, telomerase reverse transcriptase, telomerase rnA, regulation, cancer. Abbreviations: 5azadc (5-aza-2'-deoxicitidine), AV (adenoviruses), HBV (Hepatitis B Virus) HIV (Human Immunodeficiency Virus), HPV (Human papillomavirus), eBV (epstein–Barr Virus), np (nucleotide pair), OB-motive (oligonecleotide/oligosaccharide binding motive), rt (reverse transcription), Pcr (polymerase chain reacion), rnAse (ribonuclease), tert (telomerase reverse transcriptase), htert (human tert), mtert (mouse tert), Dn-htert (dominantnegative mutated htert), erβ (estrogen β receptor), HtLV-I (Human t-lymphotropic virus), tr (telomerase rnA), trAP (telomeric repeat Amplification Protocol), PHA (phytohemagglutinin), Hre (Hypoxia response element), neS (nuclear export signal).


  • Replication protein A modulates the activity of human telomerase in vitro

    by M. P. Rubtsova, D. A. Skvortsov, I. O. Petruseva, O. I. Lavrik, P. V. Spirin, V. S. Prasolov, F. L. Kisseljov, O. A. Dontsova

    Our aim was to investigate how replication protein A (RPA) in a wide range of concentration can regulate the activity of human telomerase. We used an in vitrosystem based on human cell extracts with...


  • Open Access

    Ribosomal RNA guanine-(N2)-methyltransferases and their targets

    by Petr V. Sergiev, Alexey A. Bogdanov, Olga A. Dontsova

    Five nearly universal methylated guanine-(N2) residues are present in bacterial rRNA in the ribosome. To date four out of five ribosomal RNA guanine-(N2)-methyltransferases are described. RsmC(YjjT) methylates G1207 of the 16S rRNA. RlmG(YgjO) and RlmL(YcbY) are responsible for the 23S rRNA m2G1835 and m2G2445 formation, correspondingly. RsmD(YhhF) is necessary for methylation of G966 residue of 16S rRNA. Structure of Escherichia coli RsmD(YhhF) methyltransferase and the structure of the Methanococcus jannaschii RsmC ortholog were determined. All ribosomal guanine-(N2)-methyltransferases have similar AdoMet-binding sites. In relation to the ribosomal substrate recognition, two enzymes that recognize assembled subunits are relatively small single domain proteins and two enzymes that recognize naked rRNA are larger proteins containing separate methyltransferase- and RNA-binding domains. The model for recognition of specific target nucleotide is proposed. The hypothetical role of the m2G residues in rRNA is discussed.


  • Open Access

    Methyltransferase That Modifies Guanine 966 of the 16 S rRNA

    by Dmitry V. Lesnyak, Jerzy Osipiuk, Tatiana Skarina, Petr V. Sergiev, Alexey A. Bogdanov, Aled Edwards, Alexei Savchenko, Andrzej Joachimiak, Olga A. Dontsova


  • The Conserved A-site Finger of the 23S rRNA: Just One of the Intersubunit Bridges or a Part of the Allosteric Communication Pathway?

    by Petr V. Sergiev, Sergey V. Kiparisov, Dmitry E. Burakovsky, Dmitry V. Lesnyak, Andrei A. Leonov, Alexey A. Bogdanov, Olga A. Dontsova


  • Open Access

    Construction of the ‘minimal’ SRP that interacts with the translating ribosome but not with specific membrane receptors in Escherichia coli

    by Olga N Avdeeva, Alexander G Myasnikov, Petr V Sergiev, Alexey A Bogdanov, Richard Brimacombe, Olga A Dontsova

    Escherichia coli signal recognition particle (SRP) consists of 4.5S RNA and Ffh protein. In contrast to eukaryotes, it remains unclear whether translation arrest takes place in prokaryotic cells. To study this problem we constructed a fusion of the M domain of Ffh protein with a cleavable affinity tag. This mutant Ffh, in a complex with 4.5S RNA, can bind signal peptide at the translating ribosome but is unable to bind the membrane. This SRP–ribosome complex should accumulate in the cell if translation is arrested. To test this, the complex was purified from the cells by ultracentrifugation and affinity chromatography. The composition of the complex was analyzed and found to consist of ribosomal RNAs and proteins, the Ffh M domain and 4.5S RNA. The accumulation of this complex in the cell in significant amounts indicated that SRP‐mediated translation arrest did occur in bacterial cells.